$43.40 +0.37 (0.86%) Mylan N.V. - NASDAQ

Aug. 29, 2016 | 01:55 PM
Last Trade: 43.40
Trade Time: Aug 29 01:55 PM Eastern Daylight Time
Change: +0.37 (0.86%)
Prev Close: 43.03
Open: 43.99
Bid: 43.40
Ask: 43.42
  1. David Einhorn's Top 5 New Q4 Buys

    GuruFocus | Feb. 16, 2016 | 18:51PM EST
  2. Benzinga's M&A Chatter for Wednesday February 10, 2016

    Benzinga | Feb. 10, 2016 | 21:59PM EST
  3. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  4. David Einhorn Rebounds - Somewhat

    GuruFocus | Feb. 9, 2016 | 16:12PM EST
  5. David Einhorn Comments on Mylan

    GuruFocus | Jan. 19, 2016 | 17:32PM EST
  6. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  7. Clinton To Target 'Inversions' With Exit Tax

    FoxBusiness | Dec. 9, 2015 | 14:41PM EST
  8. Pfizer-Allergan Won't Be the Last Inversion

    FoxBusiness | Nov. 23, 2015 | 12:26PM EST
  9. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  10. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  11. Pfizer-Allergan A Go Despite New Tax Inversion Rules?

    IBD | Nov. 19, 2015 | 19:05PM EST
  12. Pfizer, Allergan Near Deal As Tax Inversion Rules Loom

    IBD | Nov. 18, 2015 | 22:38PM EST
  13. Treasury Plans New 'Targeted' Tax-Inversion Crackdown

    IBD | Nov. 18, 2015 | 18:05PM EST
  14. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  15. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 15, 2015 | 20:01PM EST
Trading Center